11 /100
LOW RISK
Score updated May 29, 2026

ANIK — Anika Therapeutics, Inc. Dilution Risk Tracker

Track ANIK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANIK — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ANIK.
🔔 Track ANIK — Get forecast alerts →

💹 Market Data

Market Cap$198.25M
Shares Outstanding13.31M
Float11.30M
Cash$41.02M
Debt$25.74M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 2.2% shares (2025Q4 vs prior)
124 institutional holders · 12.25M shares
#1 BlackRock, Inc. 1.65M shares
#2 Caligan Partners LP 1.44M shares
#3 VANGUARD GROUP INC 779.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest552.2K
Days to Cover4.3
% of Float4.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ANIK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANIK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ANIK
📊 ANIK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ANIK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.